XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 48,719 $ 30,337 $ 134,185 $ 86,939
General and administrative 16,061 13,335 48,512 36,324
Total operating expenses 64,780 43,672 182,697 123,263
Loss from operations (64,780) (43,672) (182,697) (123,263)
Other income (expense), net 301 1,313 2,857 3,600
Net loss $ (64,479) $ (42,359) $ (179,840) $ (119,663)
Net loss per share, basic (in dollars per share) $ (0.66) $ (0.53) $ (1.86) $ (1.49)
Net loss per share, diluted (in dollars per share) $ (0.66) $ (0.53) $ (1.86) $ (1.49)
Weighted average common shares outstanding, basic (in shares) 97,050,637 80,606,438 96,587,149 80,115,143
Weighted average common shares outstanding, diluted (in shares) 97,050,637 80,606,438 96,587,149 80,115,143
Comprehensive loss:        
Net loss $ (64,479) $ (42,359) $ (179,840) $ (119,663)
Other comprehensive income:        
Unrealized (loss) gain on marketable securities 182 40 36 861
Total other comprehensive income 182 40 36 861
Comprehensive loss $ (64,297) $ (42,319) $ (179,804) $ (118,802)